Home / Inspections / 710676

FDA Inspection 710676 — Octapharma AB

Octapharma AB — FEI 3005559915

The FDA completed an inspection of Octapharma AB on January 20, 2011 in Stockholm. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Biologics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
January 20, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Stockholm (Sweden)

Facility

Other inspections at this facility

  • 1218250 (VAI Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1070173 (VAI Fri Sep 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 894095 (VAI Mon Apr 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 783783 (VAI Thu Jan 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 580664 (VAI Thu Jan 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources